Liquid Biopsy Surveillance and Early Detection Summit
Evvnt Promotion / evvnt
Archivio
16.11.2022 - 17.11.2022Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 07:30 - 16:00
Temi della conferenza In the wake of new FDA guidance and exciting MRD partnership announcements between Grail and AstraZeneca, Amgen and Bristol Myers Squibb the liquid biopsy industry is experiencing a paradigm shift. Touted as having the potential to transform clinical practice as we know it, technical progress and mounting investment in premetastatic applications are creating huge industry-wide excitement for liquid biopsy-based screening and surveillance for novel precision drug development.